The CDSCO has alerted healthcare professionals and consumers about stolen Novo Nordisk products, including semaglutide and insulin injectables. These products, requiring specific temperature control (2-8°C), may be compromised if improperly stored. The regulator has instructed state drug control offices to monitor the market and take action under the Drugs and Cosmetics Act, 1940, while police investigate the theft during transit.
